arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 1/2009 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    REVIEW

    Low molecular heparins for acute therapy of venous thromboembolism

    THERAPY FROM A CRITICAL VIEWPOINT

    VADT study: again no benefit with strict glucose control in type 2 diabetes mellitus

    ACCOMPLISH study: first endpoint study for starting treatment of hypertension with a combination therapy

    IN BRIEF

    Federal Joint Committee asks for reevaluation of HPV vaccination

    Olanzapin (ZYPREXA): generics have to go off market

    CURRENT ADR NETWORK REPORT

    Stroke due to intravitreal bevacizumab (AVASTIN)

    SIDE EFFECTS

    Necrosis of the jaw due to alendronate (FOSAMAX, generics)

    Fentanyl lollipops ACTIQ: fatal mix-up
    free

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles